Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT05275205
Status:
COMPLETED
Last Update Posted:
2024-08-07
First Post:
2022-02-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
Sponsor:
Unity Biotechnology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-17
First Submit QC Date:
None
Study First Post Date:
2022-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-12
Results First Submit QC Date:
None
Results First Post Date:
2024-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-12
Last Update Post Date:
2024-08-07
Last Update Post Date Type:
ACTUAL